COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy-Reference-Cited by-同舟云学术

COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy

Published:2021-10 Issue:5 Volume:11 Page:529-540
ISSN:2095-1779
Container-title:Journal of Pharmaceutical Analysis
language:en
Short-container-title:Journal of Pharmaceutical Analysis

Author:

Sinha Koel^ORCID,Som Chaudhury Sutapa^ORCID,Sharma Pramita,Ruidas Bhuban^ORCID

Publisher

Elsevier BV

Subject

Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy

Reference160 articles.

1. Relationship between chest CT manifestations and immune response in COVID-19 patients;He;Int. J. Infect. Dis.,2020

2. WHO coronavirus COVID-19, https://covid19.who.int/?gclid=Cj0KCQiAifzBRDjARIsAEElyGLzLAGDf_LYNk44vviUC34Z2_lnvxwy_IO3GXoxznnOaGjGZ60mOi8aAk1SEALw_wcB. (Accessed 24 March 2020).

3. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction;Mullis;Cold Spring Harb. Symp. Quant. Biol.,1986

4. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020

5. Coronavirus disease 2019 (COVID-19): a perspective from China;Zu;Radiology,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single primer/self-template-powered isothermal amplification for single-molecule quantification of multiple DNA glycosylases;Sensors and Actuators B: Chemical;2024-04

2. Aptamer-Based Strategies to Address Challenges in COVID-19 Diagnosis and Treatments;Interdisciplinary Perspectives on Infectious Diseases;2023-07-31

3. CRISPR/Cas14 provides a promising platform in facile and versatile aptasensing with improved sensitivity;Talanta;2023-03

4. Reduction in the COVID-19 pneumonia case fatality rate by silver nanoparticles: A randomized case study;Heliyon;2023-03

5. Natural Products and Nanotechnology Against Coronavirus Disease 2019;Frontiers in Chemistry;2022-02-10